about
Neutralization and antibody-dependent enhancement of dengue virusesRisk factors in dengue shock syndrome: a prospective epidemiologic study in Rayong, Thailand. I. The 1980 outbreakIn vivo enhancement of dengue virus infection in rhesus monkeys by passively transferred antibodyDengueA prospective seroepidemiologic study on dengue in children four to nine years of age in Yogyakarta, Indonesia I. studies in 1995-1996.Studies on the pathogenesis of dengue infection in monkeys. II. Clinical laboratory responses to heterologous infection.Dengue: hematologic aspects.Effect of immune status on dengue 2 virus replication in cultured leukocytes from infants and childrenUltrastructural studies on dengue virus infection of human lymphoblastsRecovery of dengue viruses from tissues of experimentally infected rhesus monkeysAntibody, macrophages, dengue virus infection, shock, and hemorrhage: a pathogenetic cascade.Epidemiologic studies on Dengue in Santiago de Cuba, 1997." ... and hygiene?" Our once and future mission.Immunological enhancement of dengue virus replication.Growth of dengue type 2 virus isolates in human peripheral blood leukocytes correlates with severe and mild dengue disease.Measurement of antibody-dependent infection enhancement of four dengue virus serotypes by monoclonal and polyclonal antibodies.Profiles of antibody-dependent enhancement of dengue virus type 2 infection.Tropical viral infections.Hemorrhagic fevers of Southeast Asia and South America: a comparative appraisal.The Alexander D. Langmuir Lecture. The pathogenesis of dengue. Molecular epidemiology in infectious disease.Specific lethality of silica for human peripheral blood mononuclear phagocytes, in vitro.Immune enhancement of viral infection.Selective primary health care: strategies for control of disease in the developing world. XI. Dengue.Incidence of infectious mononucleosis at the Universities of California and Hawaii.Haiti: absence of dengue hemorrhagic fever despite hyperendemic dengue virus transmission.Editorial response: Resuscitation of patients with dengue hemorrhagic fever/dengue shock syndrome.Short-term safety of live attenuated Japanese encephalitis vaccine (SA14-14-2): results of a randomized trial with 26,239 subjects.Epidemiological studies of Thai haemorrhagic fever, 1962-64.Serological studies of dengue haemorrhagic fever.Tissue culture techniques for the study of dengue viruses.Attempts at virus recovery from patients dying of Thai haemorrhagic feverRecovery of dengue and chikungunya viruses from Thai haemorrhagic fever patients by passage in sucking mice.Evaluation of suckling mice and tissue culture for recovery of viruses from haemorrhagic fever patients in ThailandInquiry into hereditary factors in the pathogenesis of dengue haemorrhagic fever: a preliminary note.Global epidemiology of dengue hemorrhagic fever.Infections with two dengue viruses in Greece in the 20th century. Did dengue hemorrhagic fever occur in the 1928 epidemic?Heterologous flavivirus infection-enhancing antibodies in sera of Nigerians.Disease severity-related antigenic differences in dengue 2 strains detected by dengue 4 monoclonal antibodies.Study of the distribution of antibody-dependent enhancement determinants on dengue 2 isolates using dengue 2-derived monoclonal antibodies.Dengue 4 virus monoclonal antibodies identify epitopes that mediate immune infection enhancement of dengue 2 viruses.
P50
Q29618172-0B2F6D52-CD34-4C21-9293-F1692C955B13Q29619424-41A89F9B-48EF-43ED-B4E9-04FB8973F21AQ29619712-1C81D977-CCC3-4A73-8DB7-3F79613F02F6Q29619772-094A5E10-986B-4886-949C-E1650C3E3DC2Q30778819-A14DCF6B-1422-4E1A-81B8-BB9F7B255E69Q33462091-4ED44DC0-D416-475A-84E1-D473FDFCBB73Q33483921-D733B493-9837-4040-984E-97DBB9298310Q34081327-BECBDD9D-C54D-4755-A59B-530F9E7E8B61Q34433336-6854A6AD-4736-45F9-B549-F50C25B21580Q37152025-6B5A8134-18FF-4E3D-B6EB-4F91115201B4Q38663807-49737DF0-041A-4EE0-BD81-92307619A323Q39038290-6214EAA8-39B5-4805-A2EC-102E4E8367DDQ39042433-A381A389-73BF-45C3-857D-9FB35962F7BFQ39042444-B8CEBC04-48F2-474E-AE67-7D688B5A4CDDQ39268311-5BEBF21B-7BEA-48B0-820C-22F4A4F82FCBQ39268319-38E3F37F-82F8-465C-BC2D-6460752DAB09Q39268329-9CFDEFA2-8BAC-4C8E-A6EB-DF788097F090Q39535343-F77D535F-EA9B-457F-951B-4E46727843D8Q39965482-BE78F6DF-CB70-4FBF-8374-A3647C13ED27Q40126879-C3B2A357-DB91-443A-8939-9AD4B49D761AQ40129691-056601A2-7A70-4119-A4CA-22DB1132CE0EQ40132021-A5BA4218-6E87-49AB-AC93-1AB70A37B23BQ40178783-61004DBB-9C8B-4B19-AA8A-6AB635E45FAAQ40275220-04BB7EBD-BD1F-4EA9-92F3-7E36C0E99E01Q40596449-F912B937-3DEE-41E2-9798-91C7A2AAE8B7Q40629433-CEA58E2D-DF66-40A9-A522-AB96CD6BB277Q40645134-E3283FA2-DA54-43F4-B5A7-22AAD8AB85AFQ40658628-8097C0D3-4445-41FB-8BAD-4D5467DBF28CQ40658878-FB1A736A-7709-46D0-8A64-FAD1279F0F47Q40659124-F67B955B-C992-48BF-9815-BA9553565147Q40659571-9DE3A29D-8E63-423B-B207-00A4F5224198Q40659655-F3C2C5DF-794C-4BE9-8795-1DD05F24BE22Q40660126-807CBCAD-2203-4FD4-A7FE-5DCF79D413DBQ40660310-2D690B8C-3504-4B41-B75A-385B6B1F71FFQ40756124-7BA7BC94-3401-4B19-B2BD-DDF2DB4351B1Q40782627-29D2585C-6557-4D0F-9709-FF2A41915CD5Q40791231-C0B27369-C417-4B2B-9DF4-E37ABE1CFA5CQ40796960-FBCFD1A5-DDBB-4EFC-B496-33C7F1B4A306Q40796967-BAA609EF-212F-4CF6-AAE6-2752B9A23DFCQ40802649-5951FA67-8AB0-49E2-9852-28F94C0EC7CC
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0002-7818-348X
@en
name
Scott B Halstead
@ast
Scott B Halstead
@en
Scott B Halstead
@nl
type
label
Scott B Halstead
@ast
Scott B Halstead
@en
Scott B Halstead
@nl
prefLabel
Scott B Halstead
@ast
Scott B Halstead
@en
Scott B Halstead
@nl
P1006
P214
P244
P1006
P106
P214
P244
P31
P3762
P496
0000-0002-7818-348X
P735
P7859
lccn-n88041368